cladribine has been researched along with Atrophy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandri, N; Battaglini, M; Cortese, R; De Stefano, N; Gentile, G; Inderyas, M; Luchetti, L; Sormani, MP | 1 |
| Heesen, C; Riemann-Lorenz, K; Scheiderbauer, J; Schiffmann, I | 1 |
| De Stefano, N; Giorgio, A | 1 |
| Battaglini, M; Dangond, F; De Leucio, A; De Stefano, N; Giorgio, A; Giovannoni, G; Hicking, C; Sormani, MP | 1 |
| Dwyer, MG; Filippi, M; Frohman, EM; Khan, O; Lassmann, H; Minagar, A; Racke, MK; Reder, AT; Stüve, O; Zivadinov, R | 1 |
1 review(s) available for cladribine and Atrophy
| Article | Year |
|---|---|
Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.
Topics: Adrenal Cortex Hormones; Alemtuzumab; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Atrophy; Brain; Cladribine; Glatiramer Acetate; Humans; Immunoglobulins, Intravenous; Interferon-beta; Multiple Sclerosis; Natalizumab; Organ Size; Peptides | 2008 |
2 trial(s) available for cladribine and Atrophy
| Article | Year |
|---|---|
Reduction in grey matter atrophy in patients with relapsing multiple sclerosis following treatment with cladribine tablets.
Topics: Atrophy; Brain; Cladribine; Disease Progression; Gray Matter; Humans; Magnetic Resonance Imaging; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Tablets | 2023 |
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.
Topics: Adolescent; Adult; Aged; Atrophy; Brain; Cladribine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Outcome Assessment, Health Care; Risk; Young Adult | 2018 |
2 other study(ies) available for cladribine and Atrophy
| Article | Year |
|---|---|
Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?
Topics: Atrophy; Brain; Cladribine; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Tablets | 2018 |
Response to 'Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?' by Schiffmann et al.
Topics: Atrophy; Brain; Cladribine; Humans; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting | 2018 |